{"DataElement":{"publicId":"3444217","version":"1","preferredName":"Gastric Cancer American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"Stage group determined from information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for gastric cancer.","longName":"3443896v1.0:3444118v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3443896","version":"1","preferredName":"Gastric Cancer Stage Grouping","preferredDefinition":"Relating to the stomach._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.","longName":"3443882v1.0:2230143v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3443882","version":"1","preferredName":"Gastric Neoplasm","preferredDefinition":"Relating to the stomach.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C13307:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric","conceptCode":"C13307","definition":"Relating to the stomach.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE9BBA38-E583-4C0E-E040-BB89AD430CAC","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"ONEDATA","dateModified":"2012-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230143","version":"1","preferredName":"Stage Grouping","preferredDefinition":"Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CC2-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE9BBA38-E621-4C0E-E040-BB89AD430CAC","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3444118","version":"1","preferredName":"Gastric Cancer American Joint Committee on Cancer Edition 7 Group Stage","preferredDefinition":"A term that refers to the staging of gastric carcinoma according to the American Joint Committee on Cancer, 7th edition._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3444118v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"13","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IA","valueDescription":"Stage IA Gastric Cancer","ValueMeaning":{"publicId":"3444122","version":"1","preferredName":"Stage IA Gastric Cancer","longName":"3444122","preferredDefinition":"Stage IA includes: T1, N0, M0.  T1: Tumor invades lamina propria, muscularis mucosae, or submucosa.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA Gastric Cancer AJCC v7","conceptCode":"C5468","definition":"Stage IA includes: T1, N0, M0.  T1: Tumor invades lamina propria, muscularis mucosae, or submucosa.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEAB03DB-ACCF-C6D9-E040-BB89AD4356B3","latestVersionIndicator":"Yes","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEAB03DB-ACE8-C6D9-E040-BB89AD4356B3","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"ONEDATA","dateModified":"2012-04-27","deletedIndicator":"No"},{"value":"IB","valueDescription":"Stage IB Gastric Cancer","ValueMeaning":{"publicId":"3444124","version":"1","preferredName":"Stage IB Gastric Cancer","longName":"3444124","preferredDefinition":"Stage IB includes: (T2, N0, M0); (T1, N1, M0).  T1: Tumor invades lamina propria, muscularis mucosae, or submucosa.  T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis.  N1: Metastasis in 1-2 regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB Gastric Cancer AJCC v7","conceptCode":"C5469","definition":"Stage IB includes: (T2, N0, M0); (T1, N1, M0).  T1: Tumor invades lamina propria, muscularis mucosae, or submucosa.  T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis.  N1: Metastasis in 1-2 regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEAB03DB-ACF5-C6D9-E040-BB89AD4356B3","latestVersionIndicator":"Yes","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEAB03DB-AD0E-C6D9-E040-BB89AD4356B3","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"ONEDATA","dateModified":"2012-04-27","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Stage IIA Gastric Cancer","ValueMeaning":{"publicId":"3444126","version":"1","preferredName":"Stage IIA Gastric Cancer","longName":"3444126","preferredDefinition":"Stage IIA includes: (T3, N0, M0); (T2, N1, M0); (T1, N2, M0). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa.  T2: Tumor invades the muscularis propria. T3: Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures.  N0: No regional lymph node metastasis.  N1: Metastasis in 1-2 regional lymph nodes.  N2: Metastasis in 3-6 regional lymph nodes.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA Gastric Cancer AJCC v7","conceptCode":"C87775","definition":"Stage IIA includes: (T3, N0, M0); (T2, N1, M0); (T1, N2, M0). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa.  T2: Tumor invades the muscularis propria. T3: Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures.  N0: No regional lymph node metastasis.  N1: Metastasis in 1-2 regional lymph nodes.  N2: Metastasis in 3-6 regional lymph nodes.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEAB03DB-AD1B-C6D9-E040-BB89AD4356B3","latestVersionIndicator":"Yes","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEAB03DB-AD34-C6D9-E040-BB89AD4356B3","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"ONEDATA","dateModified":"2012-04-27","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Stage IIB Gastric Cancer","ValueMeaning":{"publicId":"3444128","version":"1","preferredName":"Stage IIB Gastric Cancer","longName":"3444128","preferredDefinition":"Stage IIB includes: (T4a, N0, M0); (T3, N1, M0); (T2, N2, M0); (T1, N3, M0).  T1: Tumor invades lamina propria, muscularis mucosae, or submucosa.  T2: Tumor invades the muscularis propria. T3: Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures.  T4a: Tumor invades serosa (visceral peritoneum).  N0: No regional lymph node metastasis.  N1: Metastasis in 1-2 regional lymph nodes.  N2: Metastasis in 3-6 regional lymph nodes.  N3: Metastasis in seven or more regional lymph nodes.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB Gastric Cancer AJCC v7","conceptCode":"C87776","definition":"Stage IIB includes: (T4a, N0, M0); (T3, N1, M0); (T2, N2, M0); (T1, N3, M0).  T1: Tumor invades lamina propria, muscularis mucosae, or submucosa.  T2: Tumor invades the muscularis propria. T3: Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures.  T4a: Tumor invades serosa (visceral peritoneum).  N0: No regional lymph node metastasis.  N1: Metastasis in 1-2 regional lymph nodes.  N2: Metastasis in 3-6 regional lymph nodes.  N3: Metastasis in seven or more regional lymph nodes.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEAB03DB-AD41-C6D9-E040-BB89AD4356B3","latestVersionIndicator":"Yes","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEAB03DB-AD5A-C6D9-E040-BB89AD4356B3","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"ONEDATA","dateModified":"2012-04-27","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Stage IIIA Gastric Cancer","ValueMeaning":{"publicId":"3444130","version":"1","preferredName":"Stage IIIA Gastric Cancer","longName":"3444130","preferredDefinition":"Stage IIIA includes: (T4a, N1, M0); (T3, N2, M0); (T2, N3, M0).  T2: Tumor invades the muscularis propria. T3: Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures.  T4a: Tumor invades serosa (visceral peritoneum).  N1: Metastasis in 1-2 regional lymph nodes.  N2: Metastasis in 3-6 regional lymph nodes.  N3: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis.  (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA Gastric Cancer AJCC v7","conceptCode":"C5471","definition":"Stage IIIA includes: (T4a, N1, M0); (T3, N2, M0); (T2, N3, M0).  T2: Tumor invades the muscularis propria. T3: Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures.  T4a: Tumor invades serosa (visceral peritoneum).  N1: Metastasis in 1-2 regional lymph nodes.  N2: Metastasis in 3-6 regional lymph nodes.  N3: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis.  (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEAB03DB-AD67-C6D9-E040-BB89AD4356B3","latestVersionIndicator":"Yes","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEAB03DB-AD80-C6D9-E040-BB89AD4356B3","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"ONEDATA","dateModified":"2012-04-27","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Stage IIIB Gastric Cancer","ValueMeaning":{"publicId":"3444132","version":"1","preferredName":"Stage IIIB Gastric Cancer","longName":"3444132","preferredDefinition":"Stage IIIB includes: (T4b, N0, M0); (T4b, N1, M0); (T4a, N2, M0); (T3, N3, M0).  T3: Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures.  T4a: Tumor invades serosa (visceral peritoneum).  T4b: Tumor invades adjacent structures. N0: No regional lymph node metastasis.  N1: Metastasis in 1-2 regional lymph nodes.  N2: Metastasis in 3-6 regional lymph nodes.  N3: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis.  (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB Gastric Cancer AJCC v7","conceptCode":"C5470","definition":"Stage IIIB includes: (T4b, N0, M0); (T4b, N1, M0); (T4a, N2, M0); (T3, N3, M0).  T3: Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures.  T4a: Tumor invades serosa (visceral peritoneum).  T4b: Tumor invades adjacent structures. N0: No regional lymph node metastasis.  N1: Metastasis in 1-2 regional lymph nodes.  N2: Metastasis in 3-6 regional lymph nodes.  N3: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis.  (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEAB03DB-AD8D-C6D9-E040-BB89AD4356B3","latestVersionIndicator":"Yes","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEAB03DB-ADA6-C6D9-E040-BB89AD4356B3","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"ONEDATA","dateModified":"2012-04-27","deletedIndicator":"No"},{"value":"IIIC","valueDescription":"Stage IIIC Gastric Cancer","ValueMeaning":{"publicId":"3444134","version":"1","preferredName":"Stage IIIC Gastric Cancer","longName":"3444134","preferredDefinition":"Stage IIIC includes: (T4b, N2, M0); (T4b, N3, M0); (T4a, N3, M0).  T4a: Tumor invades serosa (visceral peritoneum).  T4b: Tumor invades adjacent structures. N2: Metastasis in 3-6 regional lymph nodes.  N3: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis.  (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIC Gastric Cancer AJCC v7","conceptCode":"C87777","definition":"Stage IIIC includes: (T4b, N2, M0); (T4b, N3, M0); (T4a, N3, M0).  T4a: Tumor invades serosa (visceral peritoneum).  T4b: Tumor invades adjacent structures. N2: Metastasis in 3-6 regional lymph nodes.  N3: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis.  (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEAB03DB-ADB3-C6D9-E040-BB89AD4356B3","latestVersionIndicator":"Yes","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEAB03DB-ADCC-C6D9-E040-BB89AD4356B3","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"ONEDATA","dateModified":"2012-04-27","deletedIndicator":"No"},{"value":"IV","valueDescription":"Stage IV Gastric Cancer","ValueMeaning":{"publicId":"3444136","version":"1","preferredName":"Stage IV Gastric Cancer","longName":"3444136","preferredDefinition":"Stage IV includes: (Any T, Any N, M1).  M1: Distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Gastric Cancer AJCC v7","conceptCode":"C89861","definition":"Stage IV includes: (Any T, Any N, M1).  M1: Distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEAB03DB-ADD9-C6D9-E040-BB89AD4356B3","latestVersionIndicator":"Yes","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEAB03DB-ADF2-C6D9-E040-BB89AD4356B3","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"ONEDATA","dateModified":"2012-04-27","deletedIndicator":"No"},{"value":"Stage unknown","valueDescription":"Stage Unknown","ValueMeaning":{"publicId":"3357508","version":"1","preferredName":"Stage Unknown","longName":"3357508","preferredDefinition":"A finding indicating that the extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Unknown","conceptCode":"C92207","definition":"The extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D76279-6263-2CA8-E040-BB89AD434A54","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEAB03DB-AC9C-C6D9-E040-BB89AD4356B3","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"ONEDATA","dateModified":"2012-04-27","deletedIndicator":"No"},{"value":"0","valueDescription":"Stage 0 Gastric Cancer","ValueMeaning":{"publicId":"3444120","version":"1","preferredName":"Stage 0 Gastric Cancer","longName":"3444120","preferredDefinition":"Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0 Gastric Cancer AJCC v6 and v7","conceptCode":"C7788","definition":"Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEAB03DB-ACA9-C6D9-E040-BB89AD4356B3","latestVersionIndicator":"Yes","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEAB03DB-ACC2-C6D9-E040-BB89AD4356B3","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"ONEDATA","dateModified":"2012-04-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3444117","version":"1","preferredName":"Gastric Carcinoma by AJCC v7 Stage Stage Grouping Stage","preferredDefinition":"No Value Exists:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C91222:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer by AJCC v7 Stage","conceptCode":"C91222","definition":"A term that refers to the staging of gastric carcinoma according to the American Joint Committee on Cancer, 7th edition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEAB03DB-AC73-C6D9-E040-BB89AD4356B3","latestVersionIndicator":"Yes","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"ONEDATA","dateModified":"2012-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEAB03DB-AC84-C6D9-E040-BB89AD4356B3","latestVersionIndicator":"Yes","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"COOPERM","dateModified":"2012-05-07","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3434444","version":"1","longName":"Stomach (Gastric)","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"5777528","version":"1","longName":"Stomach-Gastric","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"}],"ReferenceDocuments":[{"name":"Disease Stage","type":"Preferred Question Text","description":"Disease Stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"BEAC5F01-CC10-E258-E040-BB89AD43294B","latestVersionIndicator":"Yes","beginDate":"2012-04-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-27","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}